A Study of Baricitinib When Administered With Ketoconazole or Fluconazole in Healthy Participants
Status:
Completed
Trial end date:
2013-11-01
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to look at the effect of ketoconazole and fluconazole on
how much baricitinib gets into the blood stream. The study will also look at the tolerability
of baricitinib and ketoconazole when given together and the tolerability of baricitinib and
fluconazole when given together.
Participants will be recruited into 1 of 2 treatment groups (Group A or Group B). Each
treatment group will participate in 2 study periods. Participants will take baricitinib alone
in 1 period and baricitinib with either ketoconazole or fluconazole in the other period. This
study will last approximately 7 weeks.